Articles on Invirase

Efficacy and Safety of Ritonavir-boosted Saquinavir (Invirase) Versus Lopinavir/ritonavir (Kaletra): Final 48-week Results of the Gemini Study   - 10/30/07

Impact on Efficacy and Lipid Profiles of Saquinavir/ritonavir (Invirase) vs Lopinavir/ritonavir (Kaletra): The Gemini Study at 24 Weeks   - 7/24/07

[P46] A study on the performance of combination of Kaletra and saquinavir twice-daily regimen on a group of antiretroviral therapy experienced patients 11/27/06

[P35] Saquinavir in double protease inhibitor regimens boosted with ritonavir (r) results of the AROMA-cohort: comparison of saquinavir/atazanavir/r versus saquinavir/lopinavir/r 11/27/06

[P76] Ritonavir boosted saquinavir once daily an Indian experience 11/27/06 [P391] Switching to saquinavir 500mg-based regimens maintains antiretroviral efficacy 11/27/06

[P383] Pharmacokinetics (PK), safety, tolerability and efficacy of boosted saquinavir 500mg film coated tablets in a regimen of 1000/100mg bid plus 2 nucleoside analogues (NRTIs) in HIV+ pregnant women 11/27/06

[P378] Placental transfer of lopinavir, saquinavir, and ritonavir 11/27/06

[P373] Barriers to the development of a pediatric formulation of saquinavir 11/27/06

[P58] The Rainbow Cohort: successful initiation/switch with/from the new saquinavir 500mg formulation first results from Germany 11/27/06

[P293] Effect of boosted saquinavir on the pharmacokinetics and pharmacodynamics of racemic methadone in opiate-dependent patients on stable methadone maintenance therapy 11/27/06